Codes / ICD10CM / C72.4

C72.4 Malignant neoplasm of acoustic nerve

ICD10CM code

ICD10CM

Chat with GenHealth to automate any coding or chart task.

Name of the Condition

  • Malignant neoplasm of acoustic nerve
  • Also referred to as malignant acoustic neuroma or vestibular schwannoma

Summary

Malignant neoplasm of the acoustic nerve is a rare cancerous growth originating in the nerve responsible for transmitting sound and balance signals from the inner ear to the brain. Unlike benign acoustic neuromas, this malignant form exhibits aggressive behavior, potentially leading to significant neurological and auditory complications.

Causes

The exact cause of malignant acoustic nerve neoplasms is not fully understood. These tumors may arise from genetic mutations affecting Schwann cells, which insulate nerve fibers, leading to uncontrolled cell growth. Some cases may also result from metastasis of cancers originating elsewhere in the body.

Risk Factors

  • Family history of neurofibromatosis type 2 (NF2), a genetic disorder increasing tumor risk in the nervous system.
  • Age: Most commonly diagnosed in middle-aged adults.
  • Prior exposure to high-dose radiation, particularly during childhood.

Symptoms

  • Progressive hearing loss in the affected ear.
  • Tinnitus (ringing or buzzing in the ear).
  • Balance disturbances or dizziness.
  • Facial numbness or weakness if nearby nerves are involved.
  • Headaches or pressure in the head.

Diagnosis

Diagnosis typically involves imaging studies such as MRI or CT scans to visualize the tumor and assess its size and impact on surrounding structures. Audiometry tests evaluate hearing function, while neurological examinations assess nerve involvement. A biopsy may be performed to confirm malignancy and determine the tumor type.

Treatment Options

  • Surgery: To remove the tumor, often with the goal of preserving hearing and facial nerve function when possible.
  • Radiation therapy: Used to target and shrink the tumor, particularly for inoperable cases or to prevent regrowth.
  • Chemotherapy: May be considered for aggressive or metastatic forms, though its effectiveness varies.
  • Supportive care: Includes medications for symptom management, such as steroids for swelling or antiemetics for nausea.

Prognosis and Follow-Up

Prognosis depends on factors like tumor size, extent of spread, and response to treatment. Regular follow-up with imaging and neurological assessments is essential to monitor for recurrence or progression. Long-term outcomes may involve ongoing management of hearing loss, balance issues, or facial nerve dysfunction.

Complications

  • Permanent hearing loss or deafness.
  • Persistent balance problems or vertigo.
  • Facial nerve damage leading to weakness or paralysis.
  • Increased intracranial pressure, potentially causing headaches or vision changes.
  • Metastasis to other parts of the nervous system or body in advanced cases.

Lifestyle & Prevention

  • Avoid known carcinogens, such as excessive radiation exposure.
  • Maintain regular health check-ups, especially if you have a family history of NF2 or prior cancer.
  • Manage symptoms like tinnitus or dizziness through lifestyle adjustments, such as reducing noise exposure or using assistive devices.

When to Seek Professional Help

Seek immediate medical attention if you experience sudden or worsening hearing loss, severe dizziness, facial weakness, or persistent headaches. Early evaluation is critical for timely diagnosis and treatment planning.

Tips for Medical Coders

  • Code C72.4 is specific to malignant neoplasms of the acoustic nerve and should not be confused with benign acoustic neuromas (which use different codes).
  • Documentation should clearly indicate the malignant nature of the tumor, including biopsy results or clinical findings supporting malignancy.
  • Ensure the code aligns with the anatomical site (acoustic nerve) and excludes other cranial nerve or CNS neoplasms unless specified.
Book a walkthrough

C72.4 policy automation walkthrough

Walk through the policies, prior authorization requirements, and workflow automation opportunities connected to this code.